The partnership builds on OpenEvidence's vision to develop "medical super-intelligence" based on agentic artificial intelligence, or a system of AI agents that can be subspecialists in clinical areas.
The partnership builds on OpenEvidence's vision to develop "medical super-intelligence" based on agentic artificial intelligence, or a system of AI agents that can be subspecialists in clinical areas.
The page is ready to read now. The fuller skim-friendly version will appear here automatically.
The partnership builds on OpenEvidence's vision to develop "medical super-intelligence" based on agentic artificial intelligence, or a system of AI agents that can be subspecialists in clinical areas.
Open the app view to save this story, compare related coverage, and continue from the same source.